Courriel : bd@sidmexinovia.com
Téléphone : +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Mycomune 500 mg Tablet
Manufacturer/Marketed By : Cadila Healthcare Ltd
$9.73 $4.11
Mycomune 500 mg Tablet serves as an essential immunosuppressant, primarily designed to help prevent the rejection of vital transplanted organs, including the kidney, liver, and heart. By modulating the immune...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Mycophenolate Mofetil 500 mg
Active Pharmaceutical Ingredient
Mycomune 500 mg Tablet
9,73 $US
4,11 $US
Mycomune 500 mg Tablet serves as an essential immunosuppressant, primarily designed to help prevent the rejection of vital transplanted organs, including the kidney, liver, and heart. By modulating the immune response, this medication reduces the likelihood that the body will attack the newly transplanted organ, thereby enhancing the success rate of transplantation procedures. Patients using Mycomune should be aware of potential side effects, including an increased risk of infections due to the suppression of the immune system. It is crucial to follow your healthcare provider's instructions closely and attend regular check-ups to monitor your health while on this medication. Additionally, individuals should inform their doctor about any existing health conditions or medications they are taking to avoid adverse interactions. Mycomune 500 mg is a vital component in the post-transplant care regimen, offering hope and improved quality of life for those undergoing organ transplants. Always consult with a healthcare professional before starting or stopping any medication to ensure it is appropriate for your unique medical needs.
Active Pharmaceutical Ingredient
Uses
• Mycomune 500 mg tablet is primarily used to prevent organ rejection in patients who have undergone transplants. This medication functions as an immunosuppressant, helping to ensure that the body does not attack the newly transplanted organ. By inhibiting immune cell activity, Mycomune 500 mg tablet plays a crucial role in maintaining the compatibility of the transplanted organ. It is commonly prescribed following procedures such as kidney, liver, or heart transplants.
• In transplant scenarios, Mycomune 500 mg tablet aids in stabilizing the patient's immune response. After receiving an organ transplant, the body may perceive the new organ as foreign and initiate an immune response against it. The use of Mycomune 500 mg tablet helps to modulate this response, thereby enhancing the chances of successful transplantation. This is particularly important for long-term transplant success and patient health.
• Mycomune 500 mg tablet is beneficial for patients who require long-term immunosuppression following their transplant surgeries. By effectively managing the immune response, this medication helps to minimize the risk of acute and chronic rejection episodes. Patients taking Mycomune 500 mg tablet can experience improved outcomes and a better quality of life post-transplant. Its role is essential in the overall management of transplant care.
• The administration of Mycomune 500 mg tablet is integral in the post-operative care of transplant recipients. It is often part of a comprehensive treatment plan that includes other medications to ensure optimal immune suppression. By taking Mycomune 500 mg tablet, patients can significantly reduce the likelihood of organ rejection and promote the longevity of their transplant. This medication exemplifies the advancements in transplant medicine aimed at improving patient survival and well-being.
Benefits
Mycomune 500 mg Tablet is classified as an immunosuppressant drug. Mycomune 500 mg works by inhibiting the immune system, thereby reducing the likelihood that the body will reject transplanted organs such as a kidney, liver or heart. This drug has also shown efficacy in the treatment of certain autoimmune diseases, such as lupus, sarcoidosis, and myasthenia gravis, in comparison with other immunosuppressive drugs. Mycomune Tablet is less likely to cause infections than other medicines. It may be used in combination with other immunosuppressive drugs, such as cyclosporine, to increase the effectiveness of these drugs. Mycomune 500 mg Tablet has been used for several years in transplant patients and is effective in preventing organ rejection in the long term.
Side Effects
As with all medicines, Mycomune 500 Tablet can cause some side effects. Contact your doctor as soon as possible if you experience any of these side effects. Your doctor may be able to suggest ways to manage or reduce these side effects.
Most Common Side Effects
• Pain around the transplanted kidney
• Pain or burning when you urinated
• dark urine
• Yellowing of the skin or eyes
• Loss of muscle control
• Confusion
• Thinking problems
Common Side Effects
• Diarrhoea
• Nausea
• Vomiting
• Stomach pain
• Headache
• Rash
• Fever
• Dizziness
• Sore Throat
• Cold
• Fast heart rate
• Low blood pressure
• Low blood glucose levels
How To Use
Mycomune 500 mg Tablet can be taken on an empty stomach, at least 1 hour in advance or 2 hours after a meal. The specific dosage and duration of treatment will be determined by a doctor and will depend on the individual's condition and response to the medication. It's very important to take Mycomune 500 Tablet exactly as prescribed by your doctor, and not to change the dose or stop taking this medicine without consulting your doctor first. It's also important to keep all appointments with your doctor and the laboratory while taking this Mycomune Tablet to check your progress and to monitor for side effects.
Safety Advice
• Alcohol: It is not recommended that you drink alcohol while taking Mycomune 500 Tablet. Alcohol may increase or decrease the effectiveness of this medicine and may also increase the risk of side effects. The best advice for you is to talk to a doctor or pharmacist before consuming alcohol, and they will tell you whether it is safe or not.
• Breastfeeding: Mycomune 500 mg Tablet is considered unsafe for breastfeeding women. This medicine may pass into breast milk and harm the infant. If you are breastfeeding and taking this medicine. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for your and your baby's health.
• Liver: Mycomune 500 Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Mycomune Tablet and report any unusual symptoms or changes in liver function to their doctor. Your doctor may need to adjust the dose in cases of liver disease.
• Pregnancy: Mycomune 500 mg Tablet is not considered safe for use in pregnant women. Animal studies suggest that it may harm a developing fetus. However, if you are pregnant or planning to get pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Mycomune 500 mg while pregnant. Your doctor can help you make the best decision for you and the health of your baby.
• Driving: The use of Mycomune Tablet does not impair your ability to drive or operate machinery. However, if you experience side effects such as dizziness or drowsiness while taking Mycomune 500 Tablet, you mustn't drive or operate heavy machinery until these side effects have subsided.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.